GeneReach Biotechnology Corp. 4171.TWO Stock
GeneReach Biotechnology Corp. Price Chart
GeneReach Biotechnology Corp. 4171.TWO Financial and Trading Overview
| GeneReach Biotechnology Corp. stock price | 31 TWD |
| Previous Close | 50.5 TWD |
| Open | 50.7 TWD |
| Bid | 51.5 TWD x 0 |
| Ask | 51.6 TWD x 0 |
| Day's Range | 50.5 - 51.8 TWD |
| 52 Week Range | 46 - 89.91 TWD |
| Volume | 165.26K TWD |
| Avg. Volume | 235.69K TWD |
| Market Cap | 2.37B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 31.024097 |
| EPS (TTM) | -2.89 TWD |
| Forward Dividend & Yield | 5 (9.71%) |
| Ex-Dividend Date | September 13, 2022 |
| 1y Target Est | N/A |
4171.TWO Valuation Measures
| Enterprise Value | 2.32B TWD |
| Trailing P/E | 31.024097 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.2172472 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
GeneReach Biotechnology Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -42.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 89.91 TWD |
| 52 Week Low | 46 TWD |
| 50-Day Moving Average | 55.66 TWD |
| 200-Day Moving Average | 58.85 TWD |
4171.TWO Share Statistics
| Avg. Volume (3 month) | 235.69K TWD |
| Avg. Daily Volume (10-Days) | 158.3K TWD |
| Shares Outstanding | 45.97M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 34.96% |
| % Held by Institutions | 4.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 2.9585998 |
| Last Split Factor | 1100:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 16.32 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 1.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 23.227 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of GeneReach Biotechnology Corp.
| Country | Taiwan |
| State | N/A |
| City | Taichung |
| Address | Central Science Park |
| ZIP | 407 |
| Phone | 886 4 2463 9869 |
| Website | https://www.genereach.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers pathogen detection platforms, including equipment and reagents; and animal use medicines, biotechnology services, medical materials and equipment, and precision instruments. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan.
Q&A For GeneReach Biotechnology Corp. Stock
What is a current 4171.TWO stock price?
GeneReach Biotechnology Corp. 4171.TWO stock price today per share is 31 TWD.
How to purchase GeneReach Biotechnology Corp. stock?
You can buy 4171.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GeneReach Biotechnology Corp.?
The stock symbol or ticker of GeneReach Biotechnology Corp. is 4171.TWO.
Which industry does the GeneReach Biotechnology Corp. company belong to?
The GeneReach Biotechnology Corp. industry is Biotechnology.
How many shares does GeneReach Biotechnology Corp. have in circulation?
The max supply of GeneReach Biotechnology Corp. shares is 57.46M.
What is GeneReach Biotechnology Corp. Price to Earnings Ratio (PE Ratio)?
GeneReach Biotechnology Corp. PE Ratio is now.
What was GeneReach Biotechnology Corp. earnings per share over the trailing 12 months (TTM)?
GeneReach Biotechnology Corp. EPS is -2.89 TWD over the trailing 12 months.
Which sector does the GeneReach Biotechnology Corp. company belong to?
The GeneReach Biotechnology Corp. sector is Healthcare.